Vaqta 50 units/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FU7MJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,230
Award facts
- Contract value 100% obligated
- $3,230.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for VAQTA 50 Units/ML Syringe. The contract is valued at $3,230.28 and represents a firm fixed-price delivery order with an ultimate completion date of July 22, 2025. The award carries no set-aside designation, indicating the vendor competed in the open market. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure an extensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to military and federal healthcare systems. The VAQTA vaccine delivery under this order supports the DLA's mission to supply medical products to DoD healthcare sites. The company's consistent success in securing pharmaceutical contracts with federal agencies underscores its established reputation and capability to meet government healthcare procurement requirements efficiently and reliably.
Quick answers
Who was awarded contract SPE2DB25FU7MJ?
SPE2DB25FU7MJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FU7MJ worth?
The government has obligated $3,230 on SPE2DB25FU7MJ.
Is contract SPE2DB25FU7MJ an order under another contract?
Yes. SPE2DB25FU7MJ is a delivery order under SPE2DB22D9101, an indefinite delivery contract.
Was contract SPE2DB25FU7MJ competed?
The extent of competition for SPE2DB25FU7MJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award